Radiotherapeutic techniques for prostate cancer, dose escalation and brachytherapy.

  • Vincent Khoo
  • Published 2005 in
    Clinical oncology (Royal College of Radiologists…
There is evidence to confirm a dose-response relationship in prostate cancer. The relative benefit is dependent on the clinical prognostic risk factors (T stage, Gleason score and presenting prostate-specific antigen [PSA]) being more favourable for intermediate-risk patients. Refinement of prognostic groups and clinical threshold parameters is ongoing… CONTINUE READING